The Case For $50 Oil By Alex Kimani - Sep 26,

New Post Public Reply Private Reply Replies (0) Message Board
SaltyMutt
231
The Case For $50 Oil

By Alex Kimani - Sep 26, 2021

2021-09-24_czqvfwspl0.jpg

The oil markets appear to have successfully scaled a major wall of worry, with oil prices rebounding to multi-year highs. Brent crude settled near a three-year high at $77.25/bbl, its best level since October 2018, while WTI closed Thursday trading at $73.30/bbl, scoring the highest settlement since July. Behind the bullishness is growing optimism that looming debt trouble at China Evergrande Group (OTCPK:EGRNF) (OTCPK:EGRNY) can be contained, coupled with a lack of any hawkish surprises by the Federal Reserve. The Fed recently announced its tapering intention, thereby confirming its economic optimism. Oil demand is seen growing steadily amid an ongoing economic recovery while the supply outlook remains stable thanks to production discipline by OPEC+.

Meanwhile, adding to the bullishness is the latest EIA report that shows that U.S. crude stockpiles declined for a seventh consecutive week. According to the U.S. Energy Information Administration, U.S. crude inventories last week fell by 3.5M barrels to 414M barrels, the lowest level since October 2018. The EIA report was bullish overall, saying supplies will only get worse in the coming weeks due to stretched inventories and the fact that refiners are coming on back faster than the supply of crude oil is growing.

But another Wall Street bear is warning the oil bulls not to do a victory lap just yet.

In a recent tweet, Bloomberg Intelligence senior commodity strategist Mike McGlone says several commodities, including crude oil, may have peaked and could be poised for a "reversion to the mean," i.e., a major pullback.

"Iterations for an enduring commodity peak are growing, and the stock market may be the final support pillar. U.S. Treasury bond yields topped out in March. Copper, corn, and lumber peaked in May. The dollar has recovered since June and crude oil may have reached its apex in July, when China cut its required reserve ratio."



Reversion to the mean

McGlone notes that commodities have become highly dependent on rising equities, and says a stock-market stress test is necessary to determine which commodities are the most likely to sustain higher prices and which are due for a pullback.

Unfortunately, he says oil, copper, corn, and lumber belong to the latter category.

McGlone notes that the last two major declines in crude (2018 and 2020) were almost tick-for-tick with the S&P 500. The 20-quarter correlation between the Bloomberg Commodity Spot Index and the S&P 500 currently sits at 0.90, the highest reading since 1960. The BI analyst says the last time the correlation peaked was back in 2013, which was followed by the spectacular oil price crash of 2014, which then spread to the rest of the commodities complex.

"Now, there is a risk of WTI reverting back to its mean since 2014, which would mean a drop to around $50 a barrel," McGlone reckons.

McGlone says there's another bearish catalyst working against oil prices: Supply elasticity due to technological advancement.

"Five years ago, it cost about $50 to extract a barrel of shale crude, now it's closer to $30. Businesses have adjusted to Covid-19, as evidenced in our chart showing S&P 500 Ebit at a record high. If equity prices fall or earnings stall, the highly correlated commodity market risks a drop with greater velocity," McGlone wrote.

Skimming stones

Bloomberg Intelligence is not the only technical analyst who is bearish about the oil price outlook.

Last month, Standard Chartered Global Research described the current oil price cycle as a 'skimming stones' period of trading.

The research outfit noted that the broad pattern over the past three months has been one of sub-cycles of rallies from starting points below USD 68/bbl for Brent, followed by reversals. Unfortunately for the bulls, the cycles have been getting flatter and faster, with Stanchart saying the next move is likely to be to the downside.

Related: Oil Trading Giant Trafigura Sees $100 Oil In Late 2022

According to Stanchart, the first skimming stones sub-cycle started in late-May, culminating in a Brent high of $77.84/bbl six weeks later. The next sub-cycle started below $68/bbl on 20 July with a high of $76.38/bbl two weeks later.

On the charts, this pattern looks like skimming stones with each bounce less high than the previous one and the length between bounces gradually diminishing.

Stanchart has predicted that the end of the skimming stones phase will involve a period of consolidation followed by a breakout move towards the downside.

Stanchart says that whereas the possibility of the oil markets returning to range-bound conditions remains, the current momentum in fundamentals, particularly the surge on the spread of the delta variant, makes an eventual downside breakout more likely.

Stanchart researchers have strongly refuted Wall Street's bullish positions saying that WTI price of $65/bbl or lower is more likely than $75/bbl or higher. Stanchart says its bearish view is informed by the fact that "...a significant amount of money has already entered the market in the Wall Street-generated belief (mistaken according to our analysis) that the balances are much tighter and justify USD 80-100/bbl."

Well, at this juncture, we are more concerned about Fed policy.

With the Fed set to start paring bond purchases as soon as November and hike interest rates in response to rising inflation, the dollar appears poised for an upward trajectory, which could be bad news for oil prices and other commodities.

By Alex Kimani for Oilprice.com

https://oilprice.com/Energy/Oil-Prices/The-Ca...0-Oil.html
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Ambrosia Biosciences Unveils Promising Nonclinical Metabolic Data

Updated Category News Views 136

Ambrosia's Latest Nonclinical Revelations Ambrosia Biosciences has just thrown out some major bait at ObesityWeek® 2026. The highlight? New nonclinical data profiles for two of their understudy small molecule programs—AMB-895 and AMB-131. It may sound niche, but in this sector, promising data spins heads. Their GLP-1 receptor agonist, AMB-895, and GIP receptor...

Continue Reading
Employment Law Suit Hits ABC: Alleged Wage Violations

Updated Category News Views 60

ABC Under Fire for Labor Code Violations You know it's a rocky road when a company like American Broadcasting Companies, Inc. lands itself in hot water with accusations riding high on labor law violations. People yapping about lunch breaks? Well, that’s the ball game here. Meal and Rest Break Controversies According to a recent lawsuit filed by Blumenthal Nordrehaug...

Continue Reading
EZaccessMD Data Breach: Class Action Lawsuit Looms

Updated Category News Views 637

Data breaches are the bogeyman no one wants lurking in the shadows, and when it’s your personal info at stake, folks rightfully squirm. This recent fiasco at EZaccessMD is one of those unsettling incidents. The word on the street isn't pretty: sensitive medical data has slipped through the cracks, leaving Edelson Lechtzin LLP, a heavyweight in class action maneuvers, to...

Continue Reading
InstaHeat 35K: FOGATTI Offers Upgraded RV Furnace Control

Updated Category News Views 107

Winter RV Trips Just Got Cozier There's nothing quite like hitting the open road in an RV during the winter months. But let's face it, nobody wants to return to a cabin that's as frigid as the great outdoors. Here's where FOGATTI steps up its game with the InstaHeat Ultra 35K RV Furnace. They’ve tinkered with the thermostat to iron out more precise control, just in time...

Continue Reading
Viking Ventures: Impacts of VK2735 on Obesity Examined

Updated Category News Views 21

Viking Therapeutics Reveal Surprising Data on VK2735 The latest from Viking Therapeutics' camp is giving obesity some serious food for thought, with new data making waves at the ObesityWeek® 2026 meeting. Their investigational dual agonist, VK2735, seems to be shaking things up, as early phase clinical data shows an impressive 74% of participants managed to improve at...

Continue Reading
Uber Data Breach: Class Action Investigation Begins

Updated Category News Views 208

When Tech Meets Trouble: Uber's Data Breach Picture this: the hum of Uber rides weaving through your city, drivers none the wiser that personal info has been pried from the vaults thanks to their tech partner, Fireworks AI. Uber, folks, is in hot water once again. This isn’t just another tech hiccup; it's a legal whirlwind brewing up courtesy of Edelson Lechtzin LLP, a...

Continue Reading
D-Wave Quantum Hit with Securities Fraud Lawsuit

Updated Category News Views 251

A Legal Quagmire for D-Wave Quantum Investors Securities fraud lawsuits are like light in a dark alley—you need them when the truth's been stashed out of sight, but they illuminate the dirty and damp parts of investment strategies nobody wants to talk about. Right now, D-Wave Quantum Inc. is smack dab in the middle of such litigious action. If you had the misfortune of...

Continue Reading
KINGRVER Boosts RV Comfort with New Water Heater Lineup

Updated Category News Views 103

An Upgrade for the Open Road In the land of RV living, comfort is king—or in this case, KINGRVER. Dropping affordable upgrades for water heaters into the world of RVs, KINGRVER's CT6 lineup is like a warm hug on a chilly campsite morning. Whether you've pulled up to a wooded retreat or parked under the vast desert sky, having dependable hot water shouldn't be a gamble....

Continue Reading
CVS Study: GLP-1 Drugs Effective But Costly

Updated Category News Views 49

Can GLP-1s Deliver Value at Their Current Price? Alright, folks, here's a real-world gut check from CVS Health. They crunched some numbers using Aetna's anonymized claims data, and the results are eye-opening. These GLP-1s are showing promising health outcomes—lower hospital visits, better clinical results, yada yada. But when it comes to savings, they ain't quite...

Continue Reading
JOYEE N01 Debuts Globally with First 2,000 Deliveries

Updated Category News Views 224

JOYYE N01 Breaks into the Global Market Now, here we go, folks—a Chinese car with ambitions bigger than the Sahara. On October 28, the JOYEE N01 rolled off the assembly line and into the international scene with a lot of fanfare at FAW's Yancheng Branch. Mark my words, this isn't just another model trying to strut into the global auto arena. This event delivered the...

Continue Reading

Top 5 Most Recently Viewed Articles

Leadership Transition at Ignitis Renewables Sparks Future Growth

Updated Category News Views 134

Leadership Transition at Ignitis Renewables AB “Ignitis grup?” has announced a significant change in leadership with the resignation of Thierry Aelens, the Chief Executive Officer (CEO) of its subsidiary, UAB “Ignitis Renewables.” Aelens will step down effective at the end of March 2025 for personal reasons and to pursue new career opportunities nearer to his...

Continue Reading
Katalyze AI Elevates Innovation with New Chief AI Officer

Updated Category News Views 206

Advancing Pharmaceutical Manufacturing with AI Leadership Katalyze AI has recently announced a pivotal move to strengthen its capabilities in the fast-evolving field of pharmaceutical manufacturing. The company has appointed Hannes Bretschneider as Chief AI Officer, signaling its commitment to advancing Agentic AI architecture. This strategic initiative aims to enhance...

Continue Reading
Iran's Strait Closure: Defense Stocks on Edge Amid Shipping Risks

Updated Category News Views 325

Iran announced the temporary closure of the Strait of Hormuz for live-fire drills, raising eyebrows across trading desks. This isn't just a geopolitical stunt; it’s a shot across the bow at U. S. military presence in the region, occurring right as indirect nuclear talks unfold with Washington. A maneuver like this sends ripples through markets that thrive on stability,...

Continue Reading
Aphaia Pharma's Engagement in Revolutionary Obesity Forum

Updated Category News Views 117

Aphaia Pharma's Engagement in Revolutionary Obesity Forum Aphaia Pharma, a leading clinical-stage biopharmaceutical company, is making waves in the field of treatments for obesity and related metabolic disorders. The company has announced that its Chief Scientific Officer, Dr. Steffen-Sebastian Bolz, will share insights during a panel discussion at the much-anticipated...

Continue Reading
U.S. Strives to Diminish China's Dominance in Rare Earths

Updated Category News Views 216

Understanding the Importance of Rare Earth Elements In recent discussions, the significance of rare earth elements (REEs) has come to the forefront of international policy. These elements play a crucial role in various sectors, from technology to defense. Currently, China holds a dominant position in the production and refinement of these vital minerals, controlling...

Continue Reading